Achalasia
Understanding Achalasia, also known as Cardiospasm or Esophageal Achalasia, is crucial for accurate healthcare documentation and medical coding. This resource provides information on Achalasia diagnosis, symptoms, treatment, and ICD-10 coding for clinical professionals. Learn about esophageal manometry and other diagnostic tests for Achalasia. Improve your clinical documentation and ensure proper medical coding for this esophageal motility disorder.
Motility disorder where the lower esophageal sphincter fails to relax, hindering food passage into the stomach.
Dysphagia (difficulty swallowing), regurgitation, chest pain, heartburn, weight loss.
Gastroenterology clinics, motility labs, hospitals for endoscopic procedures.
ICD-10 Code Families
Complete code families applicable to K22.0
When to use each related code
| Description | When to use |
|---|---|
| Failure of the lower esophageal sphincter to relax. | Primary esophageal motility disorder causing dysphagia. Consider when barium swallow shows birds beak. |
| Esophageal motility disorder with chest pain and dysphagia. | Diffuse esophageal spasm if symptoms include chest pain, dysphagia. Manometry confirms diagnosis. |
| Nutcracker esophagus: high-amplitude esophageal contractions. | Diagnose with esophageal manometry showing high-amplitude peristaltic contractions and normal LES relaxation. Consider for chest pain with dysphagia. |
Best-practice checklist
- ✓Achalasia (Cardiospasm) diagnosis requires documented esophageal dysmotility.
- ✓Confirm Achalasia with esophageal manometry showing aperistalsis.
- ✓Document dysphagia, regurgitation, chest pain symptoms for Achalasia.
- ✓Rule out other esophageal motility disorders in Achalasia diagnosis.
- ✓ICD-10-CM code K22.0 for Achalasia, document supporting findings.
Common pitfalls to avoid
Risk of inaccurate coding due to similar esophageal conditions. CDI should clarify achalasia type (e.g., primary vs. secondary) for proper code assignment.
Using outdated term 'cardiospasm' can lead to coding errors. CDI should ensure accurate 'achalasia' documentation for ICD-10 compliance.
Insufficient documentation of treatment (e.g., dilation, Heller myotomy) impacts code selection and reimbursement. CDI should query physicians for treatment details.
Best-practice tips
- 01ICD-10 K22.0, Esophageal manometry for accurate Achalasia diagnosis.
- 02CDI: Document dysphagia, regurgitation, chest pain for Achalasia coding.
- 03Timely pneumatic dilation or Heller myotomy improves Achalasia outcomes.
- 04Botulinum toxin injection for Achalasia: Consider patient suitability, compliance.
- 05Monitor Achalasia patients for esophageal cancer risk, HCC surveillance.
Step-by-step checklist
- 1
1. Dysphagia to solids AND liquids? (ICD-10 K22.0)
- 2
2. Regurgitation of undigested food? Document details.
- 3
3. Weight loss? Quantify and trend for severity.
- 4
4. Esophageal manometry: Aperistalsis, incomplete LES relaxation?
- 5
5. Barium swallow: Bird's beak appearance? R/o pseudoachalasia.
Ready-to-paste narrative
Patient presents with classic symptoms of achalasia, including dysphagia to both solids and liquids, regurgitation of undigested food, chest pain, and heartburn. The patient reports progressive worsening of dysphagia over the past six months. Weight loss of approximately 10 pounds is also noted. Physical examination reveals no significant abnormalities. Differential diagnosis includes esophageal stricture, esophageal cancer, gastroesophageal reflux disease (GERD), and pseudoachalasia. To evaluate for achalasia and rule out other esophageal motility disorders, an esophagram (barium swallow) was ordered, demonstrating the characteristic bird's beak appearance of the distal esophagus. Esophageal manometry confirmed the diagnosis of achalasia, revealing aperistalsis of the esophageal body and incomplete relaxation of the lower esophageal sphincter (LES). Treatment options including pneumatic dilation, peroral endoscopic myotomy (POEM), Heller myotomy, and botulinum toxin injection were discussed with the patient. The risks and benefits of each procedure were explained, and the patient elected to proceed with pneumatic dilation as the initial treatment strategy. Follow-up appointment scheduled to assess treatment efficacy and manage potential complications such as esophageal perforation or reflux. ICD-10 code K22.0 assigned. CPT codes for diagnostic and therapeutic procedures will be determined based on the specific interventions performed.
Common questions and answers
What are the key differentiating features in the differential diagnosis of achalasia vs. pseudoachalasia in clinical practice?+
Differentiating achalasia from pseudoachalasia, which mimics achalasia's symptoms but stems from a secondary cause (e.g., malignancy), is crucial for appropriate management. Key differentiating features include age of onset (pseudoachalasia often presents later), duration of symptoms (more rapid progression in pseudoachalasia), weight loss (more prominent in pseudoachalasia), response to nitrates (better in achalasia initially), endoscopic findings (irregular narrowing or mass lesion suggesting malignancy in pseudoachalasia), and manometric features (aperistalsis and incomplete LES relaxation in achalasia, whereas pseudoachalasia may show some preserved peristalsis or a fixed, non-relaxing obstruction). Endoscopic ultrasound (EUS) and biopsy are essential to rule out malignancy in suspected pseudoachalasia cases. Explore how high-resolution manometry and timed barium esophagram can further aid in the differential diagnosis. Consider implementing a structured diagnostic approach to ensure timely and accurate diagnosis in patients presenting with dysphagia.
How can high-resolution manometry (HRM) findings help guide the selection of appropriate treatment strategies for achalasia, including pneumatic dilation and peroral endoscopic myotomy (POEM)?+
High-resolution manometry (HRM) provides detailed information about esophageal motility and pressure, crucial for classifying achalasia subtypes (I, II, and III) and guiding treatment decisions. HRM helps assess the integrated relaxation pressure (IRP), a key metric for predicting treatment outcomes. Type I achalasia (minimal esophageal pressurization) often responds well to pneumatic dilation. Type II achalasia (panesophageal pressurization) shows the best response to POEM and Heller myotomy, while Type III achalasia (spastic achalasia) may have less predictable outcomes and higher complication rates with pneumatic dilation, and may require tailored approaches such as POEM with partial fundoplication to manage spastic contractions. Consider implementing HRM as a standard part of the achalasia evaluation to personalize treatment and optimize patient outcomes. Learn more about the evolving role of HRM in predicting treatment success and long-term follow-up.
What are the best long-term management strategies for patients with achalasia post-treatment, including lifestyle modifications, pharmacologic therapies, and endoscopic follow-up?+
Long-term management of achalasia post-treatment (e.g., pneumatic dilation, Heller myotomy, POEM) focuses on symptom control and minimizing complications. Lifestyle modifications such as eating smaller meals, avoiding late-night meals, and elevating the head of the bed can improve symptom burden. Pharmacologic therapies, including nitrates and calcium channel blockers, can provide short-term relief but are not typically recommended for long-term use. Endoscopic follow-up with periodic assessments (including symptom evaluation, timed barium esophagram, and/or HRM as needed) is essential for monitoring treatment efficacy, detecting recurrent or residual achalasia, and managing potential complications like reflux esophagitis or esophageal perforation. Explore how tailored post-treatment protocols can improve long-term quality of life for achalasia patients and consider implementing patient-reported outcome measures to track symptom improvement and guide management decisions.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.